Previous close | 93.00 |
Open | 93.00 |
Bid | 100.90 |
Ask | 109.10 |
Strike | 310.00 |
Expiry date | 2025-01-17 |
Day's range | 93.00 - 93.00 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Investing.com -- There is a higher potential for downside than upside in Biogen Inc's (NASDAQ:BIIB) shares, UBS analysts said Thursday, lowering their price target on the stock from $234 to $202.
The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...